Age, Biography and Wiki
Ian Gibbons (biochemist) was born on 6 March, 1946 in England. Discover Ian Gibbons (biochemist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 67 years old?
| Popular As | N/A |
| Occupation | Researcher, Syva & Biotrack Chief Scientist, Theranos |
| Age | 67 years old |
| Zodiac Sign | Pisces |
| Born | 6 March, 1946 |
| Birthday | 6 March |
| Birthplace | England |
| Date of death | May 23, 2013 (aged 67) - Portola Valley, California, U.S. Portola Valley, California, U.S. |
| Died Place | Portola Valley, California, U.S. |
| Nationality |
We recommend you to check the complete list of Famous People born on 6 March. He is a member of famous with the age 67 years old group.
Ian Gibbons (biochemist) Height, Weight & Measurements
At 67 years old, Ian Gibbons (biochemist) height not available right now. We will update Ian Gibbons (biochemist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Who Is Ian Gibbons (biochemist)'s Wife?
His wife is Rochelle Gibbons
| Family | |
|---|---|
| Parents | Not Available |
| Wife | Rochelle Gibbons |
| Sibling | Not Available |
| Children | Not Available |
Ian Gibbons (biochemist) Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Ian Gibbons (biochemist) worth at the age of 67 years old? Ian Gibbons (biochemist)’s income source is mostly from being a successful . He is from . We have estimated Ian Gibbons (biochemist)'s net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Ian Gibbons (biochemist) Social Network
| Wikipedia |
| Imdb |
Timeline
On May 15, 2013, Gibbons was notified that he needed to appear at the Fuisz lawyers' offices on May 17 to give his deposition. After Theranos had been actively discouraging him from testifying, a Theranos lawyer emailed him a draft doctor's note that could be adapted to excuse him. On the evening of May 16, Gibbons took a combination of medication and alcohol. The following morning, he was discovered by his wife on the bathroom floor, unconscious and barely breathing. He died, aged 67, of liver failure in a hospital on May 23, 2013. When his wife called Holmes's office to report his death, Holmes did not return her call. Instead, his wife received an email from a Theranos lawyer requesting she immediately return Gibbons's company laptop and any confidential information he might have had in his possession.
In 2011, Gibbons became involved in a patent theft case involving Theranos and Richard Fuisz. The American entrepreneur and inventor had been a former friend and neighbor of Elizabeth Holmes and her family. But the two families had fallen out and Fuisz's offer to help Holmes with her invention had been declined.
In the fall of 2010, Channing Robertson alerted Holmes of Gibbons's complaints and frustrations. Gibbons was subsequently fired. Several of his colleagues lobbied on his behalf, and he was quickly rehired, with reduced responsibilities: as a technical consultant to the chemistry group he had formerly headed.
Gibbons was brought in by CEO Elizabeth Holmes in 2005 as the company's chief scientist. Gibbons was the first experienced scientist hired, with the title of senior director of assay development. As chief scientist, Gibbons often gave the staff informal lectures on biochemistry and the science of blood testing. To ensure product success, Gibbons insisted that blood test results from Theranos developmental devices need to match benchmark results of competitors' commercial analyzers. Theranos's devices often became a source of frustration for Gibbons, as they differed, sometimes significantly, from the benchmarks. His high standards became a source of friction with Theranos engineers and senior management. Senior management warned employees who questioned the accuracy of the technology. As a result of his desperation, Gibbons confided to his wife that "nothing at Theranos is working". Holmes's practice of discouraging communication between departments also troubled Gibbons. The reason given for such information siloing was that the company was operating in stealth mode to protect its trade secrets. However, it prevented effective problem solving and pursuit of common goals between employees.
Ian Gibbons (March 6, 1946 – May 23, 2013) was a British biochemist who was the chief scientist of Theranos. He worked for 30 years in the diagnostic and therapeutic industry before joining Theranos in 2005. In 2013, Gibbons intentionally took an overdose the night before he was required to testify in a lawsuit about the health company's technology. He died of liver failure several days after his suicide attempt. In 2018, Theranos collapsed after it was revealed that the company's blood testing devices had never actually worked.
